Neurologist and Nerve Pathology Lab Director @MayoClinic. Vice-Chair of Education @PNSociety1. Check my highlights to learn more about peripheral neuropathy.
Joined June 2019
- Tweets 3,985
- Following 930
- Followers 5,260
- Likes 11,502
220 Photos and videos
Pinned Tweet
Hot off the press! Nerve biopsy is more sensitive than fat aspirate and skin biopsy for amyloid diagnosis in symptomatic ATTRv peripheral neuropathy (95% vs 48% and 53%). Great @MayoClinicNeuro enterprise collaboration and strong work from Mayo MS4 and incoming @UVANeurology star resident @APanrudkevich . @GreenJournal bit.ly/4tqCXPH
3
28
90
4,666
Marcus Pinto, MD, MS retweeted
Objective markers of neuropathic pain
On Neurodiab website a signaling of articles on #diabeticneuropathy
The 231st Publication News is by Ioannis N. Petropoulos (neurodiab.eu/publication-new…)
2
4
73
It was truly a privilege to speak on the @PNSociety1 stage! What an incredible first annual meeting day! Excited for the next three days to come. 😊
1
4
37
1,351
Marcus Pinto, MD, MS retweeted
Introducing our Education Course Speakers!
Join leading experts as they discuss the broader concepts, challenges, and advances shaping the peripheral neuropathy field.
We hope you are as excited as we are!
7
7
516
I'm excited to be heading to my favorite medical conference, the @PNSociety1 meeting! Can't wait to reconnect with old friends, make new ones, and explore the latest breakthroughs in peripheral nerve disorders!
1
33
1,452
Marcus Pinto, MD, MS retweeted
Jun 11
What would an ideal #EEG competency assessment look like?🤔🧠⚡️ @ClinicalNeuroph @SBeniczky @EEGTalk
sciencedirect.com/science/ar…
12
34
2,814
Marcus Pinto, MD, MS retweeted
The 2026 Autoimmune Neurology Conference is set to advance clinical practice through innovative science. Register to attend before June 18 for the best rates. hubs.la/Q04kL3Rl0
#AANANC
1
1
6
577
Marcus Pinto, MD, MS retweeted
We were honored to welcome Dr. Jose Merino, Editor-in-Chief of Neurology, as our 2026 Residents’ Choice Visiting Professor! 🧠
His Grand Rounds presentation sparked a thoughtful discussion on the future of medical publishing. #MayoNeuroResidency
1
6
587
Marcus Pinto, MD, MS retweeted
JPNS Monthly Spotlight: Can oral Nicotinamide Riboside (NR) prevent nerve degeneration? A new Phase 2 study evaluated NR's ability to protect and regenerate small sensory axons using a capsaicin-induced human experimental model. bit.ly/4oiiziK @WileyBrainPsych
5
5
6
557
Marcus Pinto, MD, MS retweeted
🎓 Congratulations, Class of 2026!
We are so proud of all you have accomplished and cannot wait to witness the impact you’ll make on the field of neurology and beyond. #MayoNeuroResidency
1
2
13
751
Marcus Pinto, MD, MS retweeted
Jun 9
🚨🧠📚 Are you an early-career neurologist interested in education? Consider applying to the NEST, a new faculty development program to advance your career as a clinician-educator. Applications are due on July 15th. For more information, follow this link: nestneuro.vercel.app/
1
8
17
3,182
Marcus Pinto, MD, MS retweeted
Takeaways from my paper: a good neurological exam is irreplaceable.
So grateful to have published this manuscript with support from Dr Erin Abner and my fellowship director Dr Greg Jicha @UKYMedicine @UKSBCoA! 🧠
@AANmember @ContinuumAAN
Among older adults with intact cognition, presence of ≥2 frontal release signs was associated with higher risk of progression to #Dementia, supporting their use as adjuncts to cognitive screening. ja.ma/4o8fHoB
5
5
55
5,922
Marcus Pinto, MD, MS retweeted
Jun 8
Improved sensory function after treatment with high-concentration capsaicin patches over 12 months
On Neurodiab website a signaling of articles on #diabeticneuropathy
The 230th Publication News is by Gidon J Bönhof (neurodiab.eu/publication-new…)
4
9
411
Marcus Pinto, MD, MS retweeted
Presented at #ERA26:
In this 104-week trial involving patients with primary membranous nephropathy, the type II anti-CD20 antibody obinutuzumab was superior to the calcineurin inhibitor tacrolimus in inducing complete remission. Full phase 3 MAJESTY trial results: nej.md/4dZsVPD
@ERAkidney
ALT A line graph from an article published in the New England Journal of Medicine compares obinutuzumab and tacrolimus in treating primary membranous nephropathy over 104 weeks. The y-axis represents the percentage of patients relapse‑free, while the x-axis represents weeks. The graph shows two lines, one for obinutuzumab and another for tacrolimus. The image mentions the European Renal Association Congress at the top.
1
18
90
9,167
Marcus Pinto, MD, MS retweeted
My own “Charcot triad” on the father of neurology. Links to parts 2 and 3 are in the comments.
#neurology #history #neuroX #medicine
28 Jul 2022
Let's talk about Jean-Martin Charcot, the "Father of Neurology"! He casts a shadow too wide to cover in one #tweetorial. First, let's talk about his training and legacy as a teacher (and stay tuned for more about him later).
#neurotwitter #neurology #medicalhistory
1/10
1
3
11
2,034
Marcus Pinto, MD, MS retweeted
🧠 Don't miss Dr Vera Fridman speaking on diabetes-associated nerve injury!
From mechanisms to emerging therapies, discover what's next in diabetic neuropathy at the PNS Annual Meeting.
⏰ Sat 13 June | 14:45–15:15
#PNSMeeting #IDNC
2
5
387
Marcus Pinto, MD, MS retweeted
Dear PNS members, don’t miss the upcoming Inflammatory Neuropathy Consortium (INC) Virtual Grand Rounds on Friday, June 5 at 10:00 AM EST. Zoom access details have been sent to your email—please check your inbox. This session is exclusively available to PNS members.
2
1
4
488
Marcus Pinto, MD, MS retweeted
Decades of rippling & mounding. Cavin-4 autoantibody, identified at Mayo Clinic, guided rituximab therapy, with sustained clinical remission and cavin-4 IgG seronegativity, highlighting role of biomarker discovery in rare autoimmune neuromuscular disease.
jamanetwork.com/journals/jam…
5
30
2,485
I’m honored to be appointed as
Medical Director of the @MayoClinic Peripheral Nerve Pathology Laboratory. Big shoes to fill after Dr. Jim Dyck led the lab for the past 20 years. Before him, the legendary lab founder and director was Professor Peter Dyck.
I’m forever grateful to my family, mentors, and patients. I will do my best to elevate our laboratory to new heights and discover innovative therapies for our patients.
34
9
262
12,025
Marcus Pinto, MD, MS retweeted
🔦 Continuing our #SeniorSpotlight series!
Up next: Dr. Jon Lang!
🎓 Future Plans: Private practice in Neenah, WI (outpatient & inpatient general neurology)
⭐ Favorite rotation: Clinical Neurophysiology
❤️ Will miss most: The outstanding atmosphere at Mayo #MayoNeuroResidency
1
5
952
Marcus Pinto, MD, MS retweeted
May 26
New Cell Reports Medicine study extends synaptophysin autoimmunity to cerebellar ataxia and provides mechanistic evidence of pathogenicity. Builds on our prior identification of synaptophysin in neurological autoimmunity and expands the clinical phenotype cell.com/cell-reports-medici…
2
5
21
1,840